EQ
Price
$0.40
Change
+$0.03 (+8.11%)
Updated
Jul 25 closing price
Capitalization
14.38M
11 days until earnings call
GLUE
Price
$5.67
Change
-$0.04 (-0.70%)
Updated
Jul 25 closing price
Capitalization
348.76M
12 days until earnings call
Interact to see
Advertisement

EQ vs GLUE

Header iconEQ vs GLUE Comparison
Open Charts EQ vs GLUEBanner chart's image
Equillium
Price$0.40
Change+$0.03 (+8.11%)
Volume$252.47K
Capitalization14.38M
Monte Rosa Therapeutics
Price$5.67
Change-$0.04 (-0.70%)
Volume$236K
Capitalization348.76M
EQ vs GLUE Comparison Chart in %
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. GLUE commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a StrongBuy and GLUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (EQ: $0.40 vs. GLUE: $5.67)
Brand notoriety: EQ and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 23% vs. GLUE: 53%
Market capitalization -- EQ: $14.38M vs. GLUE: $348.76M
EQ [@Biotechnology] is valued at $14.38M. GLUE’s [@Biotechnology] market capitalization is $348.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than EQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 6 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • EQ’s TA Score: 6 bullish, 3 bearish.
  • GLUE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EQ is a better buy in the short-term than GLUE.

Price Growth

EQ (@Biotechnology) experienced а -2.99% price change this week, while GLUE (@Biotechnology) price change was -4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

EQ is expected to report earnings on Nov 18, 2025.

GLUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($349M) has a higher market cap than EQ($14.4M). GLUE YTD gains are higher at: -18.300 vs. EQ (-46.177). GLUE has higher annual earnings (EBITDA): 6.14M vs. EQ (-13.65M). GLUE has more cash in the bank: 326M vs. EQ (14.5M). EQ has less debt than GLUE: EQ (295K) vs GLUE (41.9M). GLUE has higher revenues than EQ: GLUE (159M) vs EQ (30.4M).
EQGLUEEQ / GLUE
Capitalization14.4M349M4%
EBITDA-13.65M6.14M-222%
Gain YTD-46.177-18.300252%
P/E RatioN/A47.25-
Revenue30.4M159M19%
Total Cash14.5M326M4%
Total Debt295K41.9M1%
FUNDAMENTALS RATINGS
EQ: Fundamental Ratings
EQ
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EQGLUE
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPBK13.420.18
+1.36%
OP Bancorp
APAM46.650.15
+0.32%
Artisan Partners Asset Management
ETR88.160.01
+0.01%
Entergy Corporation
SMP32.64-0.33
-1.00%
Standard Motor Products
CANF0.98-0.03
-2.97%
Can-Fite BioPharma Ltd

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MTNB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
+9.73%
MTNB - EQ
39%
Loosely correlated
-2.09%
IMNM - EQ
33%
Poorly correlated
-3.29%
PRQR - EQ
28%
Poorly correlated
-1.33%
WVE - EQ
26%
Poorly correlated
+0.12%
GLUE - EQ
25%
Poorly correlated
-0.70%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-0.70%
EYPT - GLUE
48%
Loosely correlated
-0.10%
ATXS - GLUE
44%
Loosely correlated
+1.37%
IMNM - GLUE
43%
Loosely correlated
-3.29%
DNLI - GLUE
42%
Loosely correlated
-4.47%
FATE - GLUE
40%
Loosely correlated
-0.80%
More